1. Home
  2. NRSN vs ILAG Comparison

NRSN vs ILAG Comparison

Compare NRSN & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • ILAG
  • Stock Information
  • Founded
  • NRSN 2017
  • ILAG 1981
  • Country
  • NRSN Israel
  • ILAG Hong Kong
  • Employees
  • NRSN N/A
  • ILAG N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • ILAG Office Equipment/Supplies/Services
  • Sector
  • NRSN Health Care
  • ILAG Consumer Discretionary
  • Exchange
  • NRSN Nasdaq
  • ILAG Nasdaq
  • Market Cap
  • NRSN 17.8M
  • ILAG 15.4M
  • IPO Year
  • NRSN 2021
  • ILAG 2022
  • Fundamental
  • Price
  • NRSN $1.14
  • ILAG $0.95
  • Analyst Decision
  • NRSN Hold
  • ILAG
  • Analyst Count
  • NRSN 1
  • ILAG 0
  • Target Price
  • NRSN N/A
  • ILAG N/A
  • AVG Volume (30 Days)
  • NRSN 360.5K
  • ILAG 17.8K
  • Earning Date
  • NRSN 12-31-2024
  • ILAG 12-27-2024
  • Dividend Yield
  • NRSN N/A
  • ILAG N/A
  • EPS Growth
  • NRSN N/A
  • ILAG N/A
  • EPS
  • NRSN N/A
  • ILAG N/A
  • Revenue
  • NRSN N/A
  • ILAG $6,443,357.00
  • Revenue This Year
  • NRSN N/A
  • ILAG N/A
  • Revenue Next Year
  • NRSN N/A
  • ILAG N/A
  • P/E Ratio
  • NRSN N/A
  • ILAG N/A
  • Revenue Growth
  • NRSN N/A
  • ILAG N/A
  • 52 Week Low
  • NRSN $0.51
  • ILAG $0.33
  • 52 Week High
  • NRSN $2.33
  • ILAG $1.35
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 56.63
  • ILAG 47.79
  • Support Level
  • NRSN $0.80
  • ILAG $0.82
  • Resistance Level
  • NRSN $1.29
  • ILAG $1.06
  • Average True Range (ATR)
  • NRSN 0.13
  • ILAG 0.08
  • MACD
  • NRSN 0.01
  • ILAG -0.00
  • Stochastic Oscillator
  • NRSN 68.75
  • ILAG 65.55

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.

Share on Social Networks: